Results 221 to 230 of about 107,195 (244)

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-vornhagen, Victoria Metaxa, Elie Azoulay   +2 more
exaly  

Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 – Part I

Expert Opinion on Therapeutic Patents, 2017
Justin J Bailey, R. Schirrmacher, Kristen Farrell, V. Bernard-Gauthier   +3 more
semanticscholar   +1 more source

Tropomyosin receptor kinase inhibitors: a patent update 2009 – 2013

Expert Opinion on Therapeutic Patents, 2014
C. Mccarthy, Edward Walker
semanticscholar   +1 more source

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul H Parikh
exaly  

Tropomyosin-related kinase C regulating the biological characteristics of breast cancer cell T47D as a dependence receptor

, 2015
Wei Zhang, Yun Niu, Shan Liu, Fengting Niu, Honghong Shen   +4 more
openalex   +1 more source

Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 – Part II

Expert Opinion on Therapeutic Patents, 2017
Justin J Bailey, R. Schirrmacher, Kristen Farrell, V. Bernard-Gauthier   +3 more
semanticscholar   +1 more source

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly